Hemostemix: Your cells, our technology

Valentin Fulga of Hemostemix  joined us at Stem Cells & Regenerative Medicine Congress 2014 to present ‘ Hemostemix Your cells, our technology’ 
  • Advantages of ACP-01
  • Ischemic heart disease clinical trial results
  •  Diversified development & commercialization opportunities

…and much more!

Get your copy here!  To find out more about  diversified development and commercialization opportunities from Hemostemix , attend  Stem Cells & Regenerative Medicine Congress USA 2015 September 2-3  in Washington, DC.